Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation

The guidelines recommend radiofrequency ablation (RFA) for early hepatocellular carcinomas that are less than 3 cm and trans-arterial chemoembolization (TACE) for intermediate-stage tumors. Real-world patient and tumor factors commonly limit strict adherence to the guidelines. We aimed to compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tay, Benjamin Wei Rong, Huang, Daniel Q., Mark, Muthiah, Thong, Neo Wee, Guan Huei, Lee, Gee, Lim Seng, Cheng, Low How, Mei, Lee Yin, Thurairajah, Prem, Chen, Lim Jia, Ng, Cheng Han, Lim, Wen Hui, Tan, Darren Jun Hao, Maureen, Da Costa, Alfred, Kow Wei Chieh, Ganpathi, Iyer Shridar, Seng, Tan Poh, Young, Dan Yock
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598932/
https://www.ncbi.nlm.nih.gov/pubmed/36289623
http://dx.doi.org/10.3390/biomedicines10102361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598932/
https://www.ncbi.nlm.nih.gov/pubmed/36289623
http://dx.doi.org/10.3390/biomedicines10102361

Ejemplares similares